Ethnic advantages in kidney transplant outcomes: The Hispanic Paradox at work?

Nephrology Dialysis Transplantation

Volumn 24, Issue 4, 2009, Pages 1103-1109

  Gordon, Elisa J ^a,b   Caicedo, Juan Carlos ^b  

^a Institute for Healthcare Studies   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Ethnic racial disparities; Graft survival; Hispanic Paradox; Outcomes; Renal transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AFRICAN AMERICAN; ASIAN; EDITORIAL; ETHNICITY; GRAFT FAILURE; GRAFT SURVIVAL; HISPANIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; SOCIAL STATUS; TREATMENT OUTCOME;

GRAFT SURVIVAL; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 65349184143     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn691     Document Type: Editorial

References (99)

1. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004; 164: 1373
2. 2006 Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1996-2005. Department of Health and Human Services, Health Resources and Services Administration, Healthcare SystemsBureau, Division of Transplantation, Rockville, MD;United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor,MI http://www.optn.org/data/ (8 January 2008, date last accessed)
3. Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242
4. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl JMed 1999; 341: 1725-1730
5. Kasiske BL, Cohen D, Lucey MR et al. Payment for immunosuppression after organ transplantation. JAMA 2000; 283: 2445-2450
6. Loubeau PR, Loubeau JM, Jantzen R. The economics of kidney transplantation versus hemodialysis. Prog Transplant 2001; 11: 291- 297
7. Woodward RS, Schnitzler MA, Lowell JA et al. Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants. Am J Transplant 2001; 1: 69- 73
8. Yen EF, Hardinger K, Brennan DC et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004; 4: 1703-1708
9. Gordon EJ. The ethics of Medicare policy: increasing transplant access and survival. DePaul Law Rev 2006; 54: 101-122
10. Rao PS, Schaubel DE, Jia X et al. Survival on dialysis post-kidney transplant failure. Am J Kidney Dis 2007; 49: 294-300
11. Hariharan A, McBride MA, Cherikh WS et al. Post-transplant renal function in the first year predicts long-termkidney transplant survival. Kidney Int 2002; 62: 311-318
12. Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health 2006; 27: 167-194
13. Hardinger KL, Stratta RJ, Egidi MF et al. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery 2001; 130: 738-745
14. Butkus DE,Mayedrech EF, Raju SS. Racial differences in the survival of cadaver renal allografts-overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840-845
15. Isaacs RB, Nock SL, Spencer CE et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34: 706-712
16. Young CJ,Gaston RS. Medical progress: renal transplantation in black Americans. N Engl J Med 2000; 343: 1545-1552
17. Greenstein SM, Kim D, Principe A et al. Renal transplantation in a heterogeneous population: the thirty-year Montefiore Medical Center experience. In: Cecka JM, Terasacki PI (eds). Clinical Transplants. Los Angeles, California: UCLA Tissue Typing Laboratory, 1998; 187-193
18. Gjertson DW. Determinants of long-term survival of adult kidney transplants: a 1999 UNOS update. Clin Transplant 1999; 341-352
19. Schold JD, Kaplan B, ChumblerNRet al.Access to quality: evaluation of the allocation of deceased donor kidneys for transplantation. J Am Soc Nephrol 2005; 16: 3121-3127
20. U.S. Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda,MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007; 90-91, 146; Tables 6.3, 7.36, 7.37; and Figure 6.20
21. Chertow GM, Milford EL. Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Adv Ren Replace Ther 1997; 4: 40-45
22. U.S. Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health,National Institute of Diabetes andDigestive and Kidney Diseases, 2005
23. Saunders PH, Banowsky LH, Reichert DF. Survival of cadaveric renal allografts in Hispanic as compared with Caucasian recipients. Transplantation1984; 37: 359-362
24. Press R, Carrasquillo O, Nickolas T et al. Race/ethnicity, poverty status, and renal transplant outcomes. Transplantation 2005; 80: 917- 924
25. Milgrom M, Gharagozloo H, Gomez C et al. Results of renal transplantation in Miami analyzed by race. Transplant Proc 1989; 21: 3934-3936
26. Kasiske BL, Neylan JF 3rd, Riggio RR et al. The effect of race on access and outcome in transplantation. N Engl J Med 1991; 324: 302-307
27. Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS update. Clin Transpl1996: 343-360
28. Caicedo JC, Butt Z, Halgrimson W et al. Outcomes after kidney transplantation in Hispanics. Am J Transplant 2008; 8: (Suppl 2): 626
29. Frankenfield DL, Rocco MV, Roman SH et al. Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J AmSoc Nephrol2003; 14: 180-186
30. Frankenfield DL, Atkinson MA, Fivush BA et al. Outcomes for adolescent Hispanic hemodialysis patients: findings from the ESRD clinical performance measures project. Am J Kidney Dis 2006; 47: 870- 878
31. Murthy BV, Molony DA, Stack AG. Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race. J Am Soc Nephrol 2005; 16: 782-790
32. Robinson BM, Joffe MM, Pisoni RL et al. Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol 2006; 17: 2910-2918
33. Peralta CA, Shlipak MG, FanDet al.Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899
34. Tareen N, Zadshir A, Martins D et al. Chronic kidney disease in African American and Mexican American populations. Kidney Int2005; 68: S137-S140
35. Benabe JE, Rios EV. Kidney disease in the Hispanic population: facing the growing challenge. J Natl Med Assoc 2004; 96: 789- 798
36. Centers for Disease Control and Prevention (CDC). Self-reported prevalence of diabetes among Hispanics-United Sates, 1994-1997. MMWR Morb Mortal Wkly Rep 1999; 48: 8-12
37. National Institute for Diabetes and Digestive and Kidney Diseases. Strategic plan on minority health disparities. Introduction: NIDDK's Mission; Area of Focus #3: End-Stage Renal Disease. [http://www. niddk.nih.gov/federal/ planning/mstrathealthplan.htm (25 October 2005, date last accessed). See pages 1 & 4
38. KauszAT, Obrador GT,Arora P et al. Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol2000; 11: 2351-2357
39. SaadeM, Joglar F. Chronic peritoneal dialysis: seven-year experience in a large Hispanic program. Perit Dial Int 1995; 15: 37-41
40. Kasiske BL, Snyder JJ, Matas AJ et al. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358-1364
41. Kasiske BL, London W, Ellison MD. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol 1998; 9: 2142-2147
42. Sequist TD, Narva AS, Stiles SK et al. Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis 2004; 44: 344-352
43. Markides KS, Eschbach K. Aging, migration, and mortality: current status of research on the Hispanic paradox. J Gerontol B Psychol Sci Soc Sci 2005; 60B: 68-75
44. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic Paradox. Ethn Dis 2001; 11: 496-518
45. Liao Y, Cooper RS, Cao G et al. Mortality among adult Hispanics: findings from the NHIS, 1986 to 1990. Am J Public Health 1998; 88: 227-232
46. Hayes-Bautista DE,Chapa J. Latino terminology: conceptual bases for standardized terminology. In: LaVeist TA (ed.). Race, Ethnicity, and Health: A Public Health Reader. San Francisco, California: Jossey Bass, 2002, 141-160
47. Hoyert DL, Heron M, Murphy SL et al. Deaths: final data for 2003. National Center for Health Statistics. Health E-Stats, 2006. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/finaldeaths03/ finaldeaths03.htm
48. Adler NE, Boyce T, Chesney MA et al. Socioeconomic inequalities in health. JAMA 1993; 269: 3140-3145
49. Syme LS, Berkman LF. Social class, susceptibility and sickness. Am J Epidemiol 1976; 104: 1-8
50. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic Paradox. In: LaVeist TA(ed.). Race, Ethnicity, and Health: A Public Health Reader. San Francisco, California: Jossey-Bass, 2002; 280-310
51. Fuentes-Afflick E, Hessol NA, Perez-Stable EJ. Testing the epidemiological paradox of low birth weight in Latinos. Arch Pediatr Adolesc Med 1999; 153: 147-153
52. Morales LS,Marielena L, Kington RS et al. Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved 2002; 13: 477-503
53. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726-2733
54. Based on OPTN Data as of 11 April 2008
55. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol2005; 16: 496-506
56. Oriol R, Le Pendu J, Chun C. Influence of the original disease, race, and center on the outcome of kidney transplantation. Transplantation1982; 33: 22-26
57. Milford EL, Ratner L, Yunis E. Will transplant immunogenetics lead to better graft survival in blacks? Racial variability in the accuracy of tissue typing for organ donation: the fourth American workshop. Transplant Proc 1987; 19(2 Suppl 2): 30-32
58. Opelz G, Pfarr E, Engelmann A et al. Kidney graft survival rates in black cyclosporine-treated recipients. Transplant Proc 1989; 21: 3918-3920
59. Kerman RH, Kimball PM, Van Buren CT et al. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 1991; 51: 338-342
60. Leffell MS, Steinberg AG, Bias WB et al. The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. Transplantation 1994; 58: 1119-1130
61. Cosio FG, Dillon JJ, Falkenhain ME et al. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int 1995; 47: 1136-1141
62. Neylan JF. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African- American renal allograft recipients. Transplantation 1997; 64: 1277- 1282
63. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine: FS506 Kidney Transplant Study Group. Transplantation 1998; 65: 515-523
64. Gaston RS, Hudson SL, Deierhoi MH et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation 1992; 53: 103-109
65. First MR, Schroeder TJ, Monaco AP et al. Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations. Clin Transplant 1996; 10: 55-59
66. LindholmA,WelshM,AltonCet al.Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability. Clin Pharmacol Ther 1992; 52: 359-371
67. Koyama H, Cecka JM. Race effects. Clin Transpl 1991: 269-280
68. Baez Y, Giron F, Nĩno-Murcia A et al. Experience with alemtuzumab (campath-1h) as induction agent in renal transplantation followed by steroid-free immunosuppression. Transplant Proc 2008; 40: 697- 699
69. Giron F, Baez Y, Nĩno-Murcia A et al. Conversion therapy to everolimus in renal transplant recipients: results after one year. Transplant Proc 2008; 40: 711-713
70. Gordon EJ. 'They don't have to suffer for me': why dialysis patients refuse offers of living donor kidneys. Med Anthropol Q 2001; 15: 1-22
71. Gordon EJ. International perspectives on organ donation. In:Weisstub DN, Diaz PintosG(eds).Autonomy and Human Rights inHealth Care: An International Perspective. Dordrecht, The Netherlands: Springer, 2008, 235-256
72. Mejia A, Halff GA, Esterl R et al. Outcome of liver transplantation in Hispanics versus non- Hispanics: is there a difference? Transplant Proc 2002; 34: 1236-1238
73. United Network for Organ Sharing (UNOS). Data request number was 070307-4. The data file was created on 5 January 2007
74. Ciancio G, Burke GW et al. Simultaneous pancreas- kidney transplantation in Hispanic recipients with type 1 diabetes mellitus and end stage renal disease. Transplant Proc 1997: 29: 3717
75. Freeman RB, Steffick DE, Guidinger MK et al. Liver and intestine transplantation in the US 1997-2006. Am J Transplant 2008; 8: 958- 976
76. Abraido-Lanza AF, Dohrenwend BP, Ng-Mak DS et al. The Latino mortality paradox: a test of the 'Salmon bias' and healthy migrant hypotheses. Am J Public Health 1999; 89: 1543-1548
77. Vega WA. The study of Latino families: a point of departure. In: Zambrana RE (ed.). Understanding Latino Families. Thousand Oaks, CA: Sage, 1995, 3-17
78. Thong MSY, Kaptein AA, Krediet RT et al. Social support predicts survival in dialysis patients. Nephrol Dial Transplant 2007; 22: 845- 850
79. LeventhalH,NerenzDR, Steele DJ. Illness representations and coping with health threats. In: Baum A, Singer JE (eds). Handbook of Psychology and Health. New York: Lawrence Erlbaum, 1984, 219-252
80. Sarkisian CA, Prohaska TR, Davis C et al. Pilot test of an attribution retraining intervention to raisewalking levels in sedentary older adults. J Am Geriatr Soc 2007; 55: 1842-1846
81. Eakin EG, Glasgow RE. The patients' perspective on the selfmanagement of chronic obstructive pulmonary disease. J Health Psychol1997; 2: 245-253
82. Lara M, Gamboa C, Iya KM et al. Acculturation and Latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health 2005; 26: 367-397
83. Gregory-Mercado KY, Staten LK, Ranger-Moore J et al. Fruit and vegetable consumption of older Mexican-American women is associated with their acculturation level. Ethn Dis 2006; 16: 89-95
84. ShahM, Zhu K, Wu H et al. Hispanic acculturation and utilization of cervical cancer screening in the US. Prev Med 2006; 42: 146-149
85. Gordon EJ. What 'race' cannot tell us about access to kidney transplantation. Camb Q Healthc Ethics 2002; 11: 134-141
86. Sue S, Dhindsa MK. Ethnic and racial health disparities research: issues and problems. Health Educ Behav 2006; 33: 459-469
87. Krieger N. Refiguring 'race': epidemiology, racialized biology, and biological expressions of race relations. Int J Health Serv 2000; 30: 211-216
88. DeVos G. Ethnic pluralism: conflict and accommodation. In: DeVos G, Romanucci-Ross L (eds). Ethnic Identity: Creation, Conflict, and Accommodation.Walnut Creek, California: Altamira Press, 1995, 15- 47
89. Borak J, Fiellin M, Chemerynski A. Who is Hispanic? Implications for epidemiological research in the United States. Epidemiology 2004; 15: 240-244
90. Pachter LM, Weller SC, Baer RD et al. Variation in asthma beliefs and practices among mainland Puerto Ricans, Mexican- Americans, Mexicans, and Guatemalans. J Asthma 2002; 39: 119- 134
91. Marin G, Marin BV. Research with Hispanic Populations, Vol. 23. Newbury Park, California: Sage, 1991
92. Lee M, Ferraro KF. Neighborhood residential segregation and physical health among Hispanic Americans: good, bad, or benign? J Health Soc Behav 2007; 48: 131-148
93. UNOS. U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients, UNOS. Transplants in theU.S. by Recipient Ethnicity.U.S. Transplants Performed: 1 January 1988-31 October 2007 (Kidney). http://www.optn.org/latestData/ rptData.asp (8 January 2008, date last accessed).
94. Caban CE. Hispanic research: implications of the National Institutes of Health Guidelines on inclusion of women and minorities in clinical research. J Natl Cancer Inst Monogr 1995; 18: 165-169
95. Stewart AL, Napoles-Springer AM. Advancing health disparities research: can we afford to ignore measurement issues? Med Care 2003; 41: 1207-1220
96. Cain VS, Kingston RS. Investigating the role of racial/ethnic bias in health outcomes. Am J Public Health 2003; 93: 191-192
97. National Alliance for Hispanic Health. Center for Science and Policy. Healthy People 2010: Hispanic Concerns Go Unanswered. Washington, D.C, 2002
98. Tanjasiri SP, Wallace SP, Shibata K. Picture imperfect: hidden problems among Asian Pacific islander elderly. Gerontologist 1995; 35: 753-760
99. U.S. Census Bureau, The. 'The American Community-Asians: 2004.' & 'The American Community-Hispanics: 2004.' American Community Survey Reports. Washington D.C. [http://www. census.gov/prod/2007pubs/acs-05.pdf] [http://www.census.gov/prod/ 2007pubs/acs-03.pdf (2 January 2008, date last accessed)